Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (8): 814-817.DOI: 10.3969/j.issn.1673-8640.2015.08.010
Previous Articles Next Articles
Received:2014-10-21
Online:2015-08-30
Published:2015-08-28
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2015.08.010
| 参数 | 不同性别的结果( | 高于参考上限[例(%)] | 低于参考下限[例(%)] | 合计[例(%)] | |||||
|---|---|---|---|---|---|---|---|---|---|
| 男性 | 女性 | P值 | 男性 | 女性 | 男性 | 女性 | |||
| MCV(fL) | 90.4±4.08 | 90.0±4.1 | 0.000 | 48(0.76) | 31(0.58) | 117(1.86) | 104(1.95) | 300(2.58) | |
| MCH(pg) | 30.1±1.4 | 29.4±1.5 | 0.000 | 22(0.35) | 6(0.11) | 86(1.36) | 269(5.05) | 383(3.29) | |
| MCHC(g/L) | 332.0±8.0 | 326.0±7.7 | 0.000 | 30(0.47) | 4(0.08) | 109(1.73) | 368(6.91) | 511(4.39) |
| 参数 | 不同性别的结果( | 高于参考上限[例(%)] | 低于参考下限[例(%)] | 合计[例(%)] | |||||
|---|---|---|---|---|---|---|---|---|---|
| 男性 | 女性 | P值 | 男性 | 女性 | 男性 | 女性 | |||
| MCV(fL) | 90.4±4.08 | 90.0±4.1 | 0.000 | 48(0.76) | 31(0.58) | 117(1.86) | 104(1.95) | 300(2.58) | |
| MCH(pg) | 30.1±1.4 | 29.4±1.5 | 0.000 | 22(0.35) | 6(0.11) | 86(1.36) | 269(5.05) | 383(3.29) | |
| MCHC(g/L) | 332.0±8.0 | 326.0±7.7 | 0.000 | 30(0.47) | 4(0.08) | 109(1.73) | 368(6.91) | 511(4.39) |
| 参数 | 第3版操作规程(2006) | 新颁布行业标准(2013) | 性别合并 | 下限变化 | 上限变化 | |
|---|---|---|---|---|---|---|
| RBC (×1012/L) | 4.09~5.74 (男) | 4.3 | ~5.8 (男) | / | ↑ | ↑ |
| 3.68~5.13 (女) | 3.8 | ~5.1 (女) | ↑ | ↓ | ||
| Hb (g/L) | 131~172 (男) | 130 | ~175 (男) | / | ↓ | ↑ |
| 113~151 (女) | 115 | ~150 (女) | ↑ | ↓ | ||
| HCT | 0.380~0.508 (男) | 0.4 | ~0.5 (男) | / | ↑ | ↓ |
| 0.335~0.450 (女) | 0.35 | ~0.45 (女) | ↑ | / | ||
| MCV (fL) | 83.9~99.1 (男) | 82 | ~100 | √ | ↓ | ↑ |
| 82.6~99.1 (女) | ||||||
| MCH (pg) | 27.8~33.8 (男) | 27 | ~34 | √ | ↓ | ↑ |
| 26.9~33.3 (女) | ||||||
| MCHC (g/L) | 320~355 (男) | 316 | ~354 | √ | ↓ | ↓ |
| 322~362 (女) | ||||||
| 参数 | 第3版操作规程(2006) | 新颁布行业标准(2013) | 性别合并 | 下限变化 | 上限变化 | |
|---|---|---|---|---|---|---|
| RBC (×1012/L) | 4.09~5.74 (男) | 4.3 | ~5.8 (男) | / | ↑ | ↑ |
| 3.68~5.13 (女) | 3.8 | ~5.1 (女) | ↑ | ↓ | ||
| Hb (g/L) | 131~172 (男) | 130 | ~175 (男) | / | ↓ | ↑ |
| 113~151 (女) | 115 | ~150 (女) | ↑ | ↓ | ||
| HCT | 0.380~0.508 (男) | 0.4 | ~0.5 (男) | / | ↑ | ↓ |
| 0.335~0.450 (女) | 0.35 | ~0.45 (女) | ↑ | / | ||
| MCV (fL) | 83.9~99.1 (男) | 82 | ~100 | √ | ↓ | ↑ |
| 82.6~99.1 (女) | ||||||
| MCH (pg) | 27.8~33.8 (男) | 27 | ~34 | √ | ↓ | ↑ |
| 26.9~33.3 (女) | ||||||
| MCHC (g/L) | 320~355 (男) | 316 | ~354 | √ | ↓ | ↓ |
| 322~362 (女) | ||||||
| [1] | 中华人民共和国卫生部. 血细胞分析参考区间[M]. 北京:中国标准出版社,2013:1-2. |
| [2] | 尚红,陈文祥,潘柏申,等. 中国成人常用肝功能和电解质及血细胞分析项目参考区间[J]. 中华检验医学杂志,2013,36(5):393-394. |
| [3] | 叶应妩,王毓三,申子瑜. 全国临床检验操作规程[M].3版.南京:东南大学出版社,2006:1018. |
| [4] | 项盈,李怀远,王静,等. 儿童专科医院检验项目的生物参考区间验证[J]. 检验医学,2011,26(11):793-794. |
| [5] | 陈桂山,杨有业,温冬梅,等. 临床生化检验项目生物参考区间适用性验证探讨[J]. 中华检验医学杂志,2008,31(2):170-174. |
| [1] | DENG Chenxia, MEI Yanping, ZHANG Xia, HUANG Baoshan, TIAN Dan, CAO Mengting, HU Yongqi, LIN Yongping, TIAN Lijun. Depolymerization effect of optical platelet count on reversible platelet aggregation after blood collection [J]. Laboratory Medicine, 2023, 38(11): 1087-1090. |
| [2] | LU Tingyan, GU Danfeng, WANG Yahong, GE Yafang, YANG Haiou. Evaluation of vaginal secretion routine determination modes and review criteria analysis [J]. Laboratory Medicine, 2023, 38(11): 1091-1097. |
| [3] | . [J]. Laboratory Medicine, 2023, 38(11): 1098-1100. |
| [4] | . [J]. Laboratory Medicine, 2023, 38(10): 983-986. |
| [5] | . [J]. Laboratory Medicine, 2023, 38(9): 901-904. |
| [6] | . [J]. Laboratory Medicine, 2023, 38(9): 905-908. |
| [7] | CHENG Xu, YANG Cunqing, PANG Bo, GU Chun, HOU Xueyun, FEI Jiaxin, WU Min, LI Jun, LIU Guijian. Number and activity of peripheral blood eosinophils in obese people [J]. Laboratory Medicine, 2023, 38(9): 855-859. |
| [8] | LEI Jing, MAN Qiuhong, ZHAO Renjia, ZHANG Tiejun, JIANG Yanfeng, XU Kelin, SUO Chen, CHEN Xingdong. Elevated red blood cell distribution width increasing the risk of heart failure：a cohort study based on the UK Biobank [J]. Laboratory Medicine, 2023, 38(9): 860-864. |
| [9] | DUAN Lili, JIANG Chang, ZHOU Dongmei. Role of PLR in ankylosing spondylitis patients with positive antinuclear antibody [J]. Laboratory Medicine, 2023, 38(7): 669-674. |
| [10] | XIA Yanyan, XIA Yongquan, SONG Guanghao, XIA Mao. Role of coagulation-related monitoring indicators in the course of rivaroxaban anticoagulation for acute venous thromboembolism in elderly patients [J]. Laboratory Medicine, 2023, 38(5): 475-478. |
| [11] | CHEN Yi, WANG Jia, XU Zhiwei, ZHAI Yaping, XUAN Weixia. Effects of different anticoagulants on phagocytosis，activation and apoptosis of in vitro neutrophil function [J]. Laboratory Medicine, 2023, 38(5): 479-483. |
| [12] | YANG Liyuan, DAI Wanqin, WANG Xiaotong, LOU Xiaoli, WANG Yue, HOU Yanqiang. Effect of peripheral blood neutrophils on interferon-gamma release assay of Mycobacterium tuberculosis [J]. Laboratory Medicine, 2023, 38(5): 484-488. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(5): 502-504. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(1): 69-72. |
| [15] | XIE Yuan, YI Wanwan, SHI Qiuyuan, LÜ Zhongwei, LIU Jin. Clinical value of thromboelastography and conventional coagulation tests in evaluating coagulation status of colon cancer and colon polyps [J]. Laboratory Medicine, 2022, 37(11): 1007-1011. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
